September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Transgene expression in the retina following AAV transduction: the WPRE effect
Author Affiliations & Notes
  • Maria Ines Patricio
    Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
  • Alun R Barnard
    Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
  • Harry Otway Orlans
    Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
  • Michelle McClements
    Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
  • Robert Maclaren
    Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
  • Footnotes
    Commercial Relationships   Maria Patricio, None; Alun Barnard, None; Harry Orlans, None; Michelle McClements, None; Robert Maclaren, None
  • Footnotes
    Support  This study was supported by the NIHR Biomedical Research Centre at the Oxford University Hospitals NHS Foundation Trust
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 1152. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Maria Ines Patricio, Alun R Barnard, Harry Otway Orlans, Michelle McClements, Robert Maclaren; Transgene expression in the retina following AAV transduction: the WPRE effect. Invest. Ophthalmol. Vis. Sci. 2016;57(12):1152.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : The use of adeno-associated virus (AAV) in retinal gene therapy for retinal diseases is increasing and an AAV1-based vector has now been approved for clinical use in the EU. The woodchuck hepatitis virus posttranslational regulatory element (WPRE) is widely used in a variety of gene therapy trials; however, it is still not clear the degree by which WPRE increases the transgene expression in retinal cells. This study investigates the effect of WPRE in driving AAV2-delivered green fluorescent protein (GFP) expression in vitro and in the mouse eye in vivo.

Methods : Two recombinant AAV2 vectors containing a hybrid human cytomegalovirus upstream enhancer with the chicken β-actin promoter (CAG) driving GFP were made with and without WPRE (rAAV2.CAG.GFP±WPRE). For in vitro analysis Human Embryonic Kidney (HEK) 293 cells were transduced with different multiplicities of infection (MOI) with both vectors, and GFP levels assessed by Western Blot. In vivo experiments involved bilateral subretinal injections of high and low dose of vectors (1E+09 and 1E+08 genome particles, respectively) in 7-week old C57BL/6J mice (N=6). Fundus autofluorescence was monitored over 5 weeks using a scanning laser ophthalmoscope. Eyes were processed after 5 weeks for histological analysis by confocal microscopy.

Results : The levels of GFP expression were evaluated at 1, 3 and 5 days post-transduction (dpt), at MOI of 250, 1000, 5000, 10000 and 20000. The ratio GFP/actin was higher in rAAV2.CAG.GFP.WPRE-transduced cells at 3 and 5 dpt. Moreover, the WPRE effect was greater at MOI 5000 and 10000, compared to rAAV2.CAG.GFP-transduced cells. Analysis of in vivo measurement of retinal fluorescence intensity showed a significant increase of the mean grey value over time for both doses [high F(4, 20)=86, p<0.001; low F(4,20)=40, p<0.001]. For the low dose, rAAV2.CAG.GFP.WPRE-injected eyes expressed significantly more GFP compared to the contralateral eye [F(1,5)=8.082, p=0.017]. Confocal microscopy analysis revealed retinal pigment epithelium cells to be the main target of GFP expression in all treated eyes; the presence of the WPRE boosted the GFP signal in the outer nuclear layer.

Conclusions : Our results confirm that WPRE significantly increases the expression of transgenes in retinal layers following delivery by an AAV2 vector. This study fully supports the use of WPRE in ongoing and future AAV gene therapy trials for eye diseases.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×